The impact of drug samples on prescribing to the uninsured

Southern Medical Journal

Volumn 101, Issue 9, 2008, Pages 888-893

  Miller, David P ^a   Mansfield, Richard J ^b   Woods, Jonathan B ^b   Wofford, James L ^b   Moran, William P ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Section of General Internal Medicine ^*

Author keywords

Drug samples; Drug utilization; Generic drugs; Pharmaceutical marketing; Physicians? practice patterns

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA GLUCOSIDASE INHIBITOR; ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTIULCER AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GASTROINTESTINAL AGENT; GENERIC DRUG; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PROTON PUMP INHIBITOR; RAUWOLFIA ALKALOID; SULFONYLUREA; VASODILATOR AGENT;

ARTICLE; CHRONIC DRUG ADMINISTRATION; DRUG COST; HEALTH INSURANCE; INTERNAL MEDICINE; LOGISTIC REGRESSION ANALYSIS; MEDICAID; MEDICAL PRACTICE; ONLINE SYSTEM; PHARMACY; PHYSICIAN; PRESCRIPTION; RETROSPECTIVE STUDY; CHI SQUARE DISTRIBUTION; CLINICAL PRACTICE; DRUG INDUSTRY; ECONOMICS; FINANCIAL MANAGEMENT; HUMAN; PATIENT; UNITED STATES;

CHI-SQUARE DISTRIBUTION; DRUG COSTS; DRUG INDUSTRY; DRUGS, GENERIC; HUMANS; MARKETING OF HEALTH SERVICES; MEDICAID; MEDICALLY UNINSURED; NORTH CAROLINA; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 53449090542     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181814d52     Document Type: Article

References (20)

1. Gagnon MA, Lexchin J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med 2008;5:e1.
2. Taira DA, Iwane KA, Chung RS. Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage. Am J Manag Care 2003;9:305-312.
3. National survey of physicians. II. Doctors and prescription drugs. Kaiser Family Foundation 2002. Available at: http://www.kff.org/rxdrugs/ 20020415b-index.cfm. Accessed February 14, 2008.
4. Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med 2005;118:881-884.
5. Boltri JM, Gordon ER, Vogel RL. Effect of anti hypertensive samples on physician prescribing patterns. Fam Med 2002;34:729-731.
6. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006;295:429-433.
7. Tietz C. Keep the sample closet door open. Minn Med 2001;84:6.
8. Shaughnessy AF, Bucci KK. Drug samples and family practice residents. Ann Pharmacother 1997;31:1296-1300.
9. Weary PE. Free drug samples. Use and abuse. Arch Dermatol 1988;124: 135-137.
10. Brewer D. The effect of drug sampling policies on residents' prescribing. Fam Med 1998;30:482-486.
11. Electronic Orange Book [Database Online]. Rockville, MD, U S Department of Health and Human Services, Food and Drug Administration, 2008. Updated February 15, 2008.
12. Chew LD, O'Young TS, Hazlet TK, et al. A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med 2000;15:478-483.
13. Lurk JT, DeJong DJ, Woods TM, et al. Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider setting. Am J Health Syst Pharm 2004;61: 267-272.
14. Alexander GC, Zhang J, Basu A. Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs. Med Care 2008;46:394-402.
15. Morelli D, Koenigsberg MR. Sample medication dispensing in a residency practice. J Fam Pract 1992;34:42-48.
16. Bower AD, Burkett GL. Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices. J Fam Pract 1987;24:612-616.
17. Lurie N, Rich EC, Simpson DE, et al. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med 1990;5:240-243.
18. Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994;271:684-689.
19. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000;283:373-380.
20. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ 1993;149:1401-1407.